Table of Contents

company-logo

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Regulus Therapeutics Dividend Announcement

• Regulus Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Regulus Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Regulus Therapeutics Dividend History

Regulus Therapeutics Dividend Yield

Regulus Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Regulus Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Regulus Therapeutics Financial Ratios

P/E ratio-2.39
PEG ratio1.38
P/B ratio1.15
ROE-53.07%
Payout ratio0.00%
Current ratio14.14
Quick ratio14.14
Cash Ratio4.07

Regulus Therapeutics Dividend FAQ

Does Regulus Therapeutics stock pay dividends?
Regulus Therapeutics does not currently pay dividends to its shareholders.
Has Regulus Therapeutics ever paid a dividend?
No, Regulus Therapeutics has no a history of paying dividends to its shareholders. Regulus Therapeutics is not known for its dividend payments.
Why doesn't Regulus Therapeutics pay dividends?
There are several potential reasons why Regulus Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Regulus Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Regulus Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Regulus Therapeutics a dividend aristocrat?
Regulus Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Regulus Therapeutics a dividend king?
Regulus Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Regulus Therapeutics a dividend stock?
No, Regulus Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Regulus Therapeutics stocks?
To buy Regulus Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Regulus Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.